Marketing Authorisation Holder
AbbVie Limited, Citywest Business Campus, Dublin 24, Ireland
Manufacturer
Fresenius Kabi Norge AS, Svinesundsveien 80, NO-1788 Halden, Norway
This medicinal product is authorised in the Member States of EEA under
the following name: Duodopa
®
�
This material was developed by AbbVie, Inc� as part of the
Risk Minimisation Plan for Levodopa/Carbidopa Intestinal Gel�
IRERMPDUO160087(1) Date of Preparation: June 2017
To Previous Page
Loading...